跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 200 条关于
“Blueprint”
全部
200
临床试验
12
药物
5
机构
5
资讯
178
去年
Agendia's BluePrint Test Shows Promise in Identifying Chemotherapy-Responsive Breast Cancer Subtypes
去年
Sanofi Acquires Blueprint Medicines for $9.1 Billion to Strengthen Rare Disease and Immunology Portfolio
去年
Blueprint Medicines Announces Positive BLU-808 Phase 1 Data and 2025 Growth Strategy
4个月前
NICE Recommends Blueprint Medicines' Ayvakyt for Advanced Systemic Mastocytosis on NHS
去年
Avapritinib Demonstrates Long-Term Benefits in Advanced Systemic Mastocytosis
去年
VantAI and Blueprint Medicines Expand Collaboration to Tackle "Undruggable" Targets with AI-Powered Proximity Therapeutics
去年
Blueprint Medicines' BLU-808 Shows Superior Profile Over Third Harmonic's THB001 in KIT Inhibitor Race
8个月前
Galecto Strengthens Leadership Team with Blueprint Medicines Veterans as DMR-001 Advances Toward Clinical Trials
9个月前
Blueprint Medicines Reports Long-Term Efficacy Data for AYVAKIT in Systemic Mastocytosis at ASH 2025
10个月前
Hepatitis C Pricing Wars of 2014 Offer Blueprint for Current GLP-1 Obesity Drug Competition
第 1 页,共 18 页
上一页
下一页